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ABSTRACT 
Introduction 
The aim of this study was to investigate knowledge and practices about influenza among patients on dialysis 
services of Italian hospitals at risk of severe influenza infection and vaccine and to identify predictive factors 
to vaccination adherence. 
Methods 
A cross-sectional observational study was carried out from January 2017 to July 2017 after the 2016/2017 
influenza vaccination campaign. The questionnaire was administered to all patients treated in seven large 
Italian dialysis services. It consisted of influenza vaccination coverage, knowledge about influenza and its 
vaccination, perceived risk of influenza complications, recommendations on influenza uptake received by 
general practitioner (GP) and nephrologist. 
Results 
Response rate was 90% (703/781). Patients’ knowledge about influenza infection and vaccine were detected 
by nine closed questions: 35.6% of responders answered correctly to ≥ 6 sentences, 47.5% of them reported 
that “influenza vaccine can cause influenza” and 45.7% believed that “antibiotics are a correct strategy to 
treat influenza”. Levels of perceived risks of hospitalisation and death were low in 39.3% and 16.5% of 
patients respectively. The adherence to the last seasonal influenza vaccination was 57.5%. The multivariate 
predictors of influenza vaccination uptake resulted: age ≥65, male, consulting TV/radio, asking information 
to GP and/or nephrologist. 
Conclusions 
The study reveals the low adherence to influenza vaccination and the subotpimal level of knowledge in 
dialysis patients. Different strategies, including a greater alliance among nephrologists and GPs to prevent 
influenza should be encouraged to improve the adherence to influenza vaccination in this at risk group. 
  
Introduction 
 
Seasonal influenza is a vaccine-preventable disease that infects approximately ten to thirty per cent of 
European population each year and causes hundreds of thousands of hospitalisations across Europe.1 Elderly, 
children and people with chronic conditions suffer the most, but everyone is at risk of developing serious 
complications, such as pneumonia, myocarditis and encephalitis, which may result in death.2-5 The most 
efficient mean for preventing a significant number of influenza infections, and the resulting morbidity and 
mortality, is an annual vaccination.6 
Ever since the first influenza vaccines were developed, the main approach has been to immunise groups at 
risk rather than whole populations. In accordance with European Centre for Disease Prevention and Control 
(ECDC) guidance and the World Health Organization (WHO), at risk groups are elderly (≥65 years) and 
people of all ages (≥6 months of age) with chronic medical conditions (such as, chronic pulmonary, 
cardiovascular, renal, hepatic and chronic neurological diseases, haematological/ metabolic disorders, 
immunosuppression due to disease or treatment, HIV/AIDS, children on long-term aspirin therapy, morbid 
obesity, neuromuscular conditions).7-9 In Europe the minimum objective is 75% of influenza vaccine 
coverage in patients with chronic medical conditions with an optimal target of 95%.7,10 The most recent 
collected influenza vaccination coverage ranged from 24.9% to 71.8% (2014–2015) rates among individuals 
with chronic medical conditions, as it was reported by nine European Member States. The remaining 23 
Member States, including Italy, were not able to report vaccination coverage rates for this group at risk.7 
Literature has explored knowledge, attitudes and risk perception on influenza infection and its vaccine 
among healthcare workers (HCWs),11-14 but there are not studies from the patient’s point of view. In a study 
Bödeker et al.15 reported that among the at risk group with underlying chronic diseases, the most commonly 
stated reasons for not being vaccinated were mistrust for the vaccination (22.3%), perception of low risk for 
influenza (21.2%), and not having considered influenza immunization yet (14.9%). Besides, 9.7% of these 
patients did not know that they belonged to the recommended group for seasonal influenza vaccination.15 A 
Canadian study found that low perceived susceptibility to influenza or severity of the infection, as well as a 
lack of interest, time or information16 are the most common reasons to opt out of influenza vaccination in 
people aged ≥60 and people with chronic medical conditions. 
This study aimed to investigate, through a questionnaire, knowledge and practices about influenza 
vaccination among patients with chronic renal disease treated at Italian hospital dialysis services. The 
research tried to identify predictors of seasonal influenza vaccine adherence in this group of patients at 
higher than average risk of adverse outcome if affected with seasonal influenza.17,18 A pilot study was 
conducted by administering the questionnaire to 54 patients in dialysis at the research coordinating hospital 
to test the understanding of the questions, ease in completing, and the simplicity of the terms. 
 
Results 
 
The response rate was of 90% (703/781), 60.9% of the interviewed patients were ≥65 with a mean age of 
67.3 [standard deviation (SD) = 13.8], 63.6% were males, 93% were Italian and 70% had a higher school 
education. There were no significant statistical differences in the distribution of age, gender, nationality and 
education level among the patients receiving treatments in the dialysis centres. The adherence to influenza 
vaccination in all dialysis centres was of 57.5% (95% CI: 53.8% – 61.1%). The percentage distributions of 
patients vaccinated against influenza in the last seasonal campaign stratified for the seven Italian hospital 
centres that participated in the survey were reported in Table 1. 
 
Table 1 – Patients vaccinated against influenza in the last seasonal campaign stratified by the 7 Italian 
hospital centers 
 Responders Vaccinated 
Italian hospital Centers N° N° (%) 
Center 1 138 98 (71.0) 
Center 2 145 78 (53.8) 
Center 3 80 33 (41.3) 
Center 4 98 76 (77.6) 
Center 5 83 28 (33.7) 
Center 6 77 32 (41.6) 
Center 7 82 59 (72.0) 
All centers 703 404 (57.5) 
 
Patients’ knowledge about influenza and vaccine were studied based on nine closed questions reported in 
Table 2. 
Table 2 – Level of patients’ knowledge about influenza and influenza vaccination (frequencies of 
correct sentences are marked in bold) (tot = 703) 
 Patients’ answers 
 True False Missing 
Sentences administrated to patients N (%) N (%) N (%) 
Influenza infection is transmitted by droplets 488 (69.4) 184 (26.2) 31 (4.4) 
Stomach influenza and influenza are caused by the same agent 157 (22.3) 527 (75.0) 19 (2.7) 
The agent of influenza is a bacterium 422 (60.0) 263 (37.4) 18 (2.6) 
The influenza vaccine can cause influenza 334 (47.5) 348 (49.5) 21 (3.0) 
Influenza infection can lead to complications 612 (87.1) 78 (11.1) 13 (1.8) 
Influenza in patient with chronic diseases can be more 
dangerous than in healthy people 
645 (91.7) 44 (6.3) 14 (2.0) 
Antibiotics are a correct strategy to treat influenza infection 321 (45.7) 365 (51.9) 17 (2.4) 
Influenza infection is transmitted by insects 177 (25.2) 507 (72.1) 19 (2.7) 
The effectiveness of the vaccine lasts for one season 564 (80.2) 121 (17.2) 18 (2.6) 
 
 
Correctly, 92% (645/703) of the patients were aware that “influenza in patient with chronic diseases can be 
more dangerous than in healthy people”, 87% (612/703) that “influenza infection can lead to complications”, 
80% (564/703) that “the effectiveness of the vaccine lasts for one season”, 75% (527/ 703) that “stomach 
influenza and influenza are not caused by the same agent”, 72% (507/703) that “influenza infection is not 
transmitted by insects”, 69% (488/703) that “influenza infection is transmitted by droplets”, 52% (365/703) 
that “antibiotics are not a correct strategy to treat influenza infection” and only 50% (348/703) that “the 
influenza vaccine cannot cause influenza”. Mistakenly, 60% (422/703) believed that “the agent of influenza 
is a bacterium”. 
Table 3 shows the distribution of patients’ characteristics and knowledge and perceived risks regarding 
influenza in all population (tot = 703) and in vaccinated patients (tot = 404). 
Table 3 – Respondents’ characteristics and knowledge and perceived risks regards to influenza in all 
sample (tot = 703) and in vaccinated patients (tot = 404). 
  All Patients Vaccinated    
Variables N° (%) % OR* 95% CI^ p Value 
DEMOGRAPHIC CHARACTERISTICS 
AGE < 65 years 269 (38.3) 39.0 -  <0.001 
 ≥ 65 years 428 (60.9) 69.2 3.5 2.5 – 4.8  
 Missing 6 (0.9)     
GENDER Male 447 (63.6) 61.7 1.6 1.2 – 2.2 <0.01 
 Female 251 (35.7) 49.6 -   
 Missing 5 (0.7)     
NATIONALITY Italian 654 (93.0) 58.9 2.0 1.1 – 3.7 <0.05 
 Other 43 (6.1) 41.9 -   
 Missing 6 (0.9)     
EDUCATION Primary school 204 (29.0) 66.2 1.7 1.2 – 2.4 <0.01 
 Over primary 492 (70.0) 53.7 -   
 Missing 7 (1.0)     
KNOWLEDGE AND PERCEIVED RISKS ABOUT INFLUENZA 
Knowledge level of influenza 
vaccination and influenza 
< 6 (scale 0-9) 450 (64.0) 58.9 1.2 0.9 – 1.6 0.3 
≥ 6 (scale 0-9) 250 (35.6) 54.8 -   
Missing 3 (0.4)     
Perceived risk level of 
hospitalization due influenza 
< 3 (scale 0-5) 276 (39.3) 60.1 1.2 0.9 – 1.6 0.3 
≥ 3 (scale 0-5) 416 (59.2) 55.8 -   
Missing 11 (1.6)     
Perceived risk of death due 
influenza 
< 3 (scale 0-5) 116 (16.5) 62.1 1.2 0.9 – 1.7 0.3 
≥ 3 (scale 0-5) 569 (80.9) 56.6 -   
Missing 18 (2.6)     
* OR: Odd Ratio 
^ CI: Confidence Interval 
 
The percentages of patients that got influenza vaccination in the last seasonal campaign were statistically 
significant higher in the ≥65 years than in the GP or nephrologist resulted in a statistically significant greater 
percentage of vaccinated patients respectively by 73.3% and 71.8%. The most used media were TV and radio 
(60.6%), followed by brochure/posters (16.5%), newspapers (15.9%), Internet (12.2%) and social networks 
(3%). Consultation of TV/radio resulted in a statistically significant greater percentage of vaccinated patients 
of 62.7%. The GP and the nephrologist advised patients to get vaccinated respectively 59.6% and 51.6% of 
cases. The patients who received the recommendation by the GP (76.8%) and by the nephrologist (74.7%) 
were vaccinated in statistically significant percentage greater than those who were not advised by GP 
(28.5%) and by nephrologist (38.9%). 
Table 4 – Persons and media consulted by patients on influenza vaccination in all sample (tot = 703) 
and in vaccinated patients (tot = 404). 
  All Patients Vaccinated    
Variables N° (%) % OR* 95% CI^ p Value 
PERSONS ASKED BY PATIENTS FOR INFORMATION ON INFLUENZA VACCINE 
GENERAL PRACTITIONER Asked 300 (42.7) 73.3 3.3 2.4 – 4.5 <0.001 
 Not Asked 402 (57.2) 45.5 -   
NEPHROLOGIST Asked 213 (30.3) 71.8 2.4 1.7 – 3.4 <0.001 
 Not Asked 489 (69.6) 51.1 -   
ANOTHER HEALTH CARE WORKER Asked 38 (5.4) 65.8 1.5 0.7 – 2.9 0.3 
 Not Asked 664 (94.5) 56.9 -   
RELATIVES / FRIENDS Asked 42 (6.0) 69.3 1.7 0.9 – 3.3 0.1 
 Not Asked 660 (93.9) 56.7 -   
OTHER PATIENTS Asked 15 (2.1) 80.0 2.3 0.7 – 7.1 0.2 
 Not Asked 687 (97.7) 56.9 -   
AT LEAST 1 OF THE ABOVE PERSONS Asked 401 (57.0) 70.1 3.5 2.6 – 4.8 <0.001 
 Not Asked 301 (42.8) 40.5 -   
MEDIA CONSULTED BY PATIENTS ABOUT INFLUENZA VACCINE 
TV / RADIO Consulted 426 (60.6) 62.7 1.7 1.3 – 2.3 <0.001 
 Not consulted 276 (39.3) 49.3 -   
NEWSPAPERS Consulted 112 (15.9) 62.5 1.3 0.8 – 1.9 0.2 
 Not consulted 590 (83.9) 56.4 -   
BROCHURE / POSTERS Consulted 116 (16.5) 62.1 1.2 0.9 – 1.7 0.3 
 Not consulted 569 (80.9) 56.6 -   
INTERNET Consulted 86 (12.2) 34.9 -   
 Not consulted 616 (87.6) 60.6 2.9 1.8 – 4.6 <0.001 
SOCIAL NETWORKS Consulted 21 (3.0) 33.3 -   
 Not consulted 681 (96.9) 58.1 2.8 1.1 – 7.4 <0.05 
RECOMMENDATION FOR INFLUENZA VACCINATION TO PATIENT BY 
GENERAL PRACTITIONER Provided 419 (59.6) 76.8 8.3 5.9 – 11.7 <0.001 
 Not provided 281 (40.0) 28.5 -   
NEPHROLOGIST Provided 363 (51.6) 74.7 4.6 3.3 – 6.3 <0.001 
 Not provided 337 (47.9) 38.9 -   
AT LEAST 1 OF THE ABOVE PERSONS Provided 501 (71.3) 74.5 17.3 11 - 27 <0.001 
 Not provided 199 (28.3) 14.6 -   
* OR: Odd Ratio 
^ CI: Confidence Interval 
 
Table 5 reports the results of the logistic regression and stepwise logistic regression analyses. Independent 
factors of multivariate analyses with positive impact on administration of influenza vaccination were: age 
≥65 (OR = 3.0), male (OR = 1.7), consulting TV/radio (OR = 1.6), asking information to GP (OR = 2.5) or to 
nephrologist (OR = 2.2). 
Table 5 – Multivariate predictors of influenza vaccination adherence among patient in dialysis. 
 Logistic regression Stepwise logistic regression analyses 
Variables OR* (95% CI) p Value OR (95% CI) p Value 
Age ≥ 65 years 2.9 (2.0 – 4.2) <0.001 3.0 (2.1 – 4.4) <0.001 
Male 1.7 (1.2 – 2.4) <0.01 1.7 (1.2 – 2.4) <0.01 
Italian nationality 0.8 (0.4 – 1.6) 0.5 - - 
Primary school education 1.3 (0.9 – 2.0) 0.5 - - 
TV / radio consulted 1.5 (1.0 – 2.1) <0.05 1.6 (1.1 – 2.3) <0.01 
Newspapers consulted 1.4 (0.9 – 2.1) 0.2 - - 
Internet consulted 0.5 (0.3 – 0.8) <0.05 0.5 (0.3 – 0.8) <0.01 
Social networks consulted 1.0 (0.4 – 3.1) 0.9 - - 
General practitioners asked by patients 2.5 (1.8 – 3.7) <0.001 2.5 (1.8 – 3.6) <0.001 
Nephrologists asked by patients 2.1 (1.4 – 3.2) <0.001 2.2 (1.5 – 3.3) <0.001 
* OR: Odd Ratio 
^ CI: Confidence Interval 
 
 
Discussion 
 
This paper is the first study on a large scale about knowledge and practices regarding the influenza in a 
specific “influenza vaccination risk group” who are patients on dialysis. Besides, the research tried to 
identify predictors of seasonal influenza vaccine adherence in this group of patients. The study reveals the 
low adherence to influenza vaccination and the suboptimal level of knowledge about influenza infection in 
the population at higher risk of adverse outcome that can be reduced by influenza vaccination. The global 
adherence to influenza vaccination in all dialysis centres joining in the study was 57.5%. The percentage was 
insufficient if we consider that the minimum goal of influenza vaccine coverage in patients with chronic 
pathologies like dialysis, has been fixed by the Italian National Plan for Vaccine Prevention at 75%, with 
optimal target of 95%.10 The rate varied across hospitals with the highest value of 77.6% and a the lowest of 
33.7%. The wide range of the values is difficult to explain. There were no differences in the clinical settings 
that may account for this, or differences in distribution of age, gender, nationality and education level among 
patients receiving treatments in the dialysis centres that participated in the study. The first predictive factor 
for influenza vaccination adherence emerged in the survey were the subjects over 65, in agreement with 
other studies.19-21 Most likely, this result is related to the fact that in Italy a national programme, consolidated 
over the years, recommended the seasonal influenza vaccination to all healthy and not healthy subjects over 
65. Therefore, patients in dialysis have to receive influenza vaccine for two reasons; either because they are 
elderly or a part of a at risk group. On the other hand, young people can only be “engaged” if recognized as 
being at high risk. To increase the younger population’s awareness of being at high risk because of severity 
of the diseases as well as reinforcing the proactive role of GP and/or nephrologist, they have to strongly 
suggest vaccination to dialysis patients of all ages which could be the strategy to support the uptake of 
seasonal influenza vaccines also in the younger patients. The media that patients consulted about influenza 
vaccine most are TV/radio. Among all media, TV/radio and newspapers are statistically significant in 
influencing patients in their decision to vaccinate against influenza. Other studies reported that awareness 
acquired through the media was one of major predictors of high influenza vaccine uptake in Europe and the 
USA.22,23 
An interesting finding that deserves further insights is the role of the Internet in predicting the influenza 
vaccination uptake: patients who searched information on the Internet about vaccination were vaccinated 
less. Among the media tools, the Internet seems to be the least reliable to provide correct information on 
health topics and, in this case, on influenza vaccination. This is an emerging issue to which the medical class 
is trying to cope with. The last few years have seen a dangerous and often painful surge in the circulation of 
inaccurate and sometimes false information, in news with sometimes dramatic consequences on the health of 
the population. Italian state authorities and professional associations have set up websites24,25 to offer to the 
population an accessible information, scientifically solid and always transparent. GPs play a central role in 
relationship with the nephrologists in the management of influenza disease. Most of patients indicated they 
obtained information about influenza vaccine from their family GP and not from their nephrologist. The 
nephrologists may expect the patient’s primary care providers to take responsibility of preventive care, while 
GPs may expect the prescribing nephrologists to take responsibility of preventive care associated with 
dialysis treatment.26 A strategy to improve the adherence to influenza vaccination among dialysis patients 
could be to strengthen the collaboration between GPs and nephrologists via shared electronic task 
dashboards or other technology-based solutions. Because of the poor knowledge regarding how influenza 
infection is transmitted, the agent of influenza, the pharmacological treatment of the influenza disease, the 
risk of the vaccination to cause influenza, the patients reported to have a high awareness of the risk of 
hospitalisation and death due to influenza, even if they were not influenced to get the vaccine. 
Recommendation for influenza vaccination received by GP or nephrologist has positively influenced patients 
in getting vaccinated. Previous studies have emphasized the importance of advice from HCWs to strongly 
influence the decision for influenza vaccination.27-31 They are a good source of patient information, and 
should be the focus of prevention efforts. This could include trainings and materials to encourage patients at 
risk of influenza complications to be vaccinated. There are some limitations to the interpretation of the study 
results. Since data was generated by a selfadministered questionnaire, they are not necessarily objective and 
may be different from reality. On the other hand, unvaccinated persons may have been less motivated to 
participate in this survey,32 and vaccination rates may be overestimated because of this non-response bias. 
Finally, some participants did not answer all questions, which also limit the accuracy of the data. In 
conclusion, this study underlines the important role of GP and nephrologist in obtaining high vaccination 
coverage of patient in dialysis through their recommendation to get vaccinated. With this perspective the 
practitioners should be trained about the strategies demonstrated in literature to increase vaccination 
successfully. These strategies could be counselling during routine visit, patient information materials, 
reminders to patients (telephone or email) and providers on medical charts.33 
 
Methods 
 
The cross-sectional observational study was carried out from January 2017 to July 2017 after the 2016/2017 
influenza vaccination campaign. The survey was conducted through interviews based on a questionnaire 
given to the patients treated in dialysis services of seven Italian hospitals. The sample size of 703 patients is 
calculated in order to extend the results obtained of sample to the entire Italian population of dialysis patients 
(about 50.000). The questionnaire, reported in the Supplement 1, investigated respondents’ influenza 
vaccination coverage, their knowledge on influenza infection and its vaccination, perceived risk of 
complications, and recommendations received by GP and nephrologist. After obtaining the written consent, 
the questionnaire was handed to patients during the dialysis session and collected after it was completed. A 
HCW may help patients to read the forms and fill out the forms. Data collected from the questionnaires were 
entered in an Excel spreadsheet and were analysed using the statistical software Stata/IC 13.0, Stata Corp LP, 
United States. Summery statistics contain the assessment of the sample characteristics and factors associated 
to influenza vaccination adherence. Bivariate statistics (chi-square test) were used to compare vaccinated and 
unvaccinated patients regarding the following items: personal characteristics (age, gender, nationality, 
education), type of media (TV/radio, newspapers, brochure/posters, Internet, social networks), people from 
whom patients got information (GP, nephrologist, other HCWs, family/ friends/colleagues, other patients in 
dialysis), patients’ levels of knowledge about influenza disease and influenza vaccine, perceived risks of 
hospitalisation and death due to influenza, and physicians (GP or nephrologist). Statistical significance was 
defined as p ≤ 0.05. Because some variables could have been confounding factors in comparison to the 
others, multivariate logistic regression model was used to adjust the odds ratios, taking into account all the 
included variables. To this purpose, in the model, all the variables with results associated with the outcome 
variable of the univariate analysis were included. Variables with a p-value ≤0.05 in the univariate analysis 
were entered in the first step of the multivariable analyses. Therefore, non-significant factors (>0.1) were 
removed from the model in a stepwise backward procedure to obtain the final model. The variables that did 
not maintain association in the final model were considered not associated after correction by confounding 
factors.34 This study protocol was approved by the Regional Ethical Committee in the session of March 28, 
2017. 
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